ArticleEuropean heart journal2020

EMPEROR-Reduced supports the use of SGLT2 inhibitors for the treatment of patients with heart failure and reduced ejection fraction: Comment on the EMPEROR-Reduced trial.

Giovanna Liuzzo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.